CHICAGO--(BUSINESS WIRE)--GE Healthcare today announced the availability of Serena Bright™ in the United States. Serena Bright™ is the industry’s first contrast-enhanced guided biopsy solution and ...
This study recruited 65 women of whom 94% were node-positive, and 60% were hormone receptor-negative. The pCR rate was 41.5% and 53.8% for the whole cohort and the hormone receptor–negative subgroup, ...
15don MSN
Doctor explains how modern imaging and scarless biopsies are changing early breast cancer diagnosis
Dr Jyoti Arora highlights the importance of attending breast cancer screening and getting tested if required, to help with early diagnosis of the condition.
Black patients are more likely than other racial and ethnic groups to have a biopsy delay of 90 days or more after an abnormal mammogram. Yellow Dog Productions/The Image Bank via Getty Images While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results